A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients-Reference-Cited by-同舟云学术

A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients

Published:2022-03 Issue: Volume:59 Page:103675
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Sharma Kanika,Chaudhary Durgesh,Beard Katherine,Srivastava Samiksha,Khalid Syed Hassan,Sriwastava Shitiz^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference78 articles.

1. Pathology and disease mechanisms in different stages of multiple sclerosis;Lassmann;J. Neurol. Sci.,2013

2. Inflammatory cortical demyelination in early multiple sclerosis;Lucchinetti;N. Engl. J. Med.,2011

3. Pathological mechanisms in progressive multiple sclerosis;Mahad;Lancet Neurol.,2015

4. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N. Engl. J. Med.,2010

5. EXPAND clinical investigators. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study;Kappos;Lancet,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning;Clinical Gastroenterology and Hepatology;2024-08

2. Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders;Expert Review of Molecular Diagnostics;2024-03-27

3. Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review;Annals of Clinical and Translational Neurology;2024-02-16

4. An update on managing patients with multiple sclerosis in primary care;JAAPA;2024-01-17

5. An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis;Expert Opinion on Pharmacotherapy;2023-03-04